ClinicalTrials.govpublic full text
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
atopic dermatitis, pruritus, eczema, topical therapy, jak inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 854087
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.